Sign in
4

Changes in Ownership

Akebia Therapeutics, Inc. Filed Acc 0001562180-17-003207

Director sold 1,188 shares at $19.64 ($23,332)

From the SEC's structured data for this filing

Trades in this filing

Nash Duane · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2017-10-02 Sale : show line 1 in the form −1,188 $19.64 $23,332 22,499 D
Open-market sales · 1,188 sh · avg $19.64 · $23,332
Loading xslF345X03/primarydocument.xml…